ECSP22034742A - Salmonella enteritidis recombinante y su uso como vacuna porcina - Google Patents
Salmonella enteritidis recombinante y su uso como vacuna porcinaInfo
- Publication number
- ECSP22034742A ECSP22034742A ECSENADI202234742A ECDI202234742A ECSP22034742A EC SP22034742 A ECSP22034742 A EC SP22034742A EC SENADI202234742 A ECSENADI202234742 A EC SENADI202234742A EC DI202234742 A ECDI202234742 A EC DI202234742A EC SP22034742 A ECSP22034742 A EC SP22034742A
- Authority
- EC
- Ecuador
- Prior art keywords
- salmonella enteritidis
- strain
- porcine circovirus
- circovirus type
- swine vaccine
- Prior art date
Links
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 4
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 4
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 230000010354 integration Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Cepa de Salmonella enteritidis 3934var Dwaal atenuada y no patógena de fenotipo rugoso modificada para expresar el xeno-antígeno de la proteína de la cápside (CAP) de circovirus porcino tipo 2 y el procedimiento de obtención de dicha cepa de Salmonella enteritidis modificada. Vacuna porcina viva, recombinante, eficaz e inocua contra circovirus porcino tipo 2 desarrollada mediante un proceso de inserción e integración del xeno-antígeno de la proteína de la cápside (CAP) del circovirus porcino tipo 2 en el cromosoma o plásmido de la cepa atenuada y no patógena Salmonella enteritidis 3934var Dwaal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2019002588A PE20211141A1 (es) | 2019-12-19 | 2019-12-19 | Salmonella enteritidis recombinante y su uso como vacuna porcina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP22034742A true ECSP22034742A (es) | 2022-11-30 |
Family
ID=76478846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202234742A ECSP22034742A (es) | 2019-12-19 | 2022-03-30 | Salmonella enteritidis recombinante y su uso como vacuna porcina |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR120779A1 (es) |
| CO (1) | CO2022008650A2 (es) |
| EC (1) | ECSP22034742A (es) |
| MX (1) | MX2022007508A (es) |
| PE (1) | PE20211141A1 (es) |
| WO (1) | WO2021125982A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2985037A1 (es) * | 2023-03-30 | 2024-11-04 | Recombina Sl | Sistema vacunal basado en cepas mutantes de Salmonella |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150959A1 (en) * | 2008-12-15 | 2010-06-17 | Vectogen Pty Ltd. | PCV 2-Based Methods and Compositions for the Treatment of Pigs |
| CN103739717B (zh) * | 2014-01-15 | 2015-07-22 | 北京市农林科学院 | 一种抗猪2型圆环病毒病的重组蛋白亚单位疫苗 |
| KR102055215B1 (ko) * | 2015-12-28 | 2020-01-22 | 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 | 돼지 써코바이러스 2형 캡시드 단백질 및 이를 포함하는 약학적 조성물의 제조 방법 |
| EA201800494A1 (ru) * | 2016-03-07 | 2019-07-31 | Вирджиния Тех Интеллектуал Пропертис, Инк. | Вакцины против химерного цирковируса свиней типа 2 (pcv2) |
| PE20171768A1 (es) * | 2017-06-12 | 2017-12-21 | Farm Veterinarios S A C | Obtencion de una salmonela enteritidis tipo rugosa y sus modificaciones geneticas para uso como vacuna aviar |
| CN109125719B (zh) * | 2017-06-19 | 2022-06-14 | 普莱柯生物工程股份有限公司 | 一种含猪圆环病毒3型、猪圆环病毒2型抗原的免疫原性组合物及其应用 |
| CN107337718B (zh) * | 2017-06-20 | 2021-06-01 | 山东省农业科学院畜牧兽医研究所 | 一种编码猪圆环病毒2型Cap蛋白的基因及其应用 |
| CN107841507B (zh) * | 2017-11-23 | 2021-05-11 | 南京农业大学 | 一种高效表达的猪圆环病毒2型Cap-穿膜肽融合蛋白基因及其应用 |
-
2019
- 2019-12-19 PE PE2019002588A patent/PE20211141A1/es unknown
-
2020
- 2020-11-05 WO PCT/PE2020/000013 patent/WO2021125982A1/es not_active Ceased
- 2020-11-05 MX MX2022007508A patent/MX2022007508A/es unknown
- 2020-12-17 AR ARP200103508A patent/AR120779A1/es unknown
-
2022
- 2022-03-30 EC ECSENADI202234742A patent/ECSP22034742A/es unknown
- 2022-06-21 CO CONC2022/0008650A patent/CO2022008650A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2022008650A2 (es) | 2022-06-30 |
| WO2021125982A1 (es) | 2021-06-24 |
| MX2022007508A (es) | 2022-07-11 |
| PE20211141A1 (es) | 2021-06-25 |
| AR120779A1 (es) | 2022-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR069882A1 (es) | Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e | |
| DOP2022000067A (es) | Vacunas para vhb y métodos de tratamiento de vhb | |
| CL2018000587A1 (es) | Adenovirus oncolítico que codifica una proteína b7 (divisional de sol. n° 2731-2017) | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| MX2016016722A (es) | Coronavirus. | |
| CL2017000982A1 (es) | Coagonistas de los receptores de glucagón y de glp-1 | |
| AR133161A2 (es) | Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos | |
| AR102006A1 (es) | Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos | |
| MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
| EA201800494A1 (ru) | Вакцины против химерного цирковируса свиней типа 2 (pcv2) | |
| AR110632A1 (es) | Vectores del adenovirus canino | |
| MX2016003855A (es) | Composicion de vacuna de circovirus porcino tipo 2b divergente y procedimientos de uso. | |
| CO2018010874A2 (es) | Vacuna de virus de zika atenuado vivo | |
| CO2019012289A2 (es) | Obtención de una salmonela enteritidis tipo rugosa y sus modificaciones genéticas para uso como vacuna aviar | |
| PE20190397A1 (es) | Virus de enteritis de pato y usos del mismo | |
| CO2018001339A2 (es) | Sistema vector de adenovirus aviar 9 (fadv-9) y métodos asociados | |
| PH12019501320A1 (en) | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning | |
| PH12018501368A1 (en) | M hyo multivalent vaccine and uses thereof | |
| ECSP22034742A (es) | Salmonella enteritidis recombinante y su uso como vacuna porcina | |
| MX2017008087A (es) | Virus de la viruela porcina recombinante y vacunas. | |
| MX394998B (es) | Virus de vacuna del sindrome respiratorio y reproductivo porcino. | |
| PH12018502576A1 (en) | Multivalent recombinant spv | |
| AR090472A1 (es) | Virus de la enfermedad de marek modificado y vacunas elaboradas con el | |
| CL2019003108A1 (es) | Obtención de una salmonela enteritidis tipo rugosa y sus modificaciones genéticas para uso como vacuna aviar. | |
| MX2024007379A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. |